Results
1 -
10 of
22
(Click
here to explore results)
- Drug Discovery for Psychiatric Disorders, CHAPTER 3 Monoaminergic Approaches for Treatment of Schizophrenia. David P. Rotella
, 2012
, Pages 35-55
- Drug Discovery for Psychiatric Disorders, CHAPTER 8 Beyond SSRIs: Second-generation Reuptake Inhibitors for the Treatment of Depression. Peter T. Gallagher
, 2012
, Pages 184-225
- Nuclear Magnetic Resonance: Volume 37, NMR in living systems. M. J. W. Prior
, 2008
, Volume 37
, Pages 327-356
- Drug Design Strategies: Quantitative Approaches, Chapter 11 Expert Systems: The Use of Expert Systems in Drug Design-Toxicity and Metabolism. Anthony Long, Kristina Fielding, Nicole McSweeney, Martin Payne, Ella Smoraczewska
, 2012
, Pages 279-311
- Phenotypic Drug Discovery, Chapter 10 Use of Phenotypic Screening in Mice in the Development of a Novel Non-D2-Receptor-Targeting Drug for the Treatment of Schizophrenia. E. Leahy, M. Varney, D. Brunner
, 2021
, Pages 175-197
- Designing Multi-Target Drugs, Chapter 2 Clinical Need and Rationale for Multi-Target Drugs in Psychiatry. Mohammed Shahid
, 2012
, Pages 14-31
- Nuclear Magnetic Resonance: Volume 38, NMR in living systems. M. J. W. Prior
, 2009
, Volume 38
, Pages 411-449
- Light in Forensic Science: Issues and Applications, CHAPTER 8 Novel Psychoactive Substances (NPS) and Recent Scenarios: Epidemiological, Anthropological and Clinical Pharmacological Issues. J. M. Corkery, L. Orsolini, D. Papanti, F. Schifano
, 2018
, Pages 207-256
- Drug Discovery for Schizophrenia, CHAPTER 8 GSK3 Networks in Schizophrenia. Jivan Khlghatyan, Gohar Fakhfouri, Jean-Martin Beaulieu
, 2015
, Pages 173-201
- Nuclear Magnetic Resonance: Volume 43, Chapter 13 NMR in living systems. M. J. W. Prior
, 2014
, Volume 43
, Pages 495-550